Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences
Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences SANTA CLARA, Calif., Jan. 9, 2017 Highlights: Focused R&D expansion providing core competencies in biosensor chemistries and bioassay solutions targeting pharma/biopharma applications for near and long-term portfolio expansion Broadens cell analysis portfolio with addition of complementary plate reader-based cellular assays Accelerates expansion into pharma/biopharma discovery and... Read more